Gailen D. Marshall
Experienced in Emphysema

Dr. Gailen D. Marshall

Allergy and Immunology
State Of Mississippi - University Of Mississippi Medical Center
2500 N State St, 
Jackson, MS 
Accepting New Patients
Offers Telehealth
Experienced in Emphysema
State Of Mississippi - University Of Mississippi Medical Center
2500 N State St, 
Jackson, MS 
OverviewInsuranceLocationsClinical Research

Overview

Gailen Marshall is an Allergy and Immunologist in Jackson, Mississippi. Dr. Marshall is rated as an Experienced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Asthma, Allergic Rhinitis, Hives, and Chronic Spontaneous Urticaria (CSU). Dr. Marshall is currently accepting new patients.

His clinical research consists of co-authoring 97 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Emphysema.

Specialties
Allergy and Immunology
Licenses
Internal Medicine in MS
Hospital Affiliations
University Of Mississippi Med Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Magnolia Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

STATE OF MISSISSIPPI - UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
2500 N State St, Jackson, MS 39216

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
Enrollment Status: Active_not_recruiting
Publish Date: August 01, 2025
Pomegranate Supplementation and Well-Being Among Medical Students and Residents
Pomegranate Supplementation and Well-Being Among Medical Students and Residents
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2025
Intervention Type: Other, Dietary supplement
Study Phase: Not Applicable
An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients With Moderate to Severe COVID-19
An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients With Moderate to Severe COVID-19
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Biological
Study Drug: Anti-COVID-19 Plasma
Study Phase: Early Phase 1
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Enrollment Status: Completed
Publish Date: September 25, 2023
Intervention Type: Drug
Study Drugs: Infliximab, Abatacept, Remdesivir, Cenicriviroc
Study Phase: Phase 3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Drug
Study Drug: TJ003234
Study Phase: Phase 2/Phase 3
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations
Enrollment Status: Completed
Publish Date: January 19, 2023
Intervention Type: Drug
Study Drug: PARTICS using QVAR
Study Phase: Phase 4
Effects of Immulina Dietary Supplementation on Innate and Adaptive Immune Measures in Normal Human Volunteers
Effects of Immulina Dietary Supplementation on Innate and Adaptive Immune Measures in Normal Human Volunteers
Enrollment Status: Completed
Publish Date: May 19, 2022
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 6 Less Clinical Trials

101 Total Publications

Corrigendum to 'Inflammatory pathways in patients with post-acute sequelae of COVID-19' [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515].
Corrigendum to 'Inflammatory pathways in patients with post-acute sequelae of COVID-19' [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515].
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: December 09, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Marshall's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile